BRIEF-Wuzhou Zhongheng's unit plans to invest in pharma firm Oramed
July 02, 2015 at 07:12 AM EDT
* Says unit plans to invest $52 million in Oramed Ltd to acquire 10 percent stakes and exclusive license of insulin products distribution in China
